Literature DB >> 28508982

Renal hemorrhage caused by acquired inhibitors to coagulation factors VIII and V in a hemodialysis patient.

Naoya Niwa1,2, Tadashi Yoshida3,4, Ryuichi Mizuno2, Mototsugu Oya2, Matsuhiko Hayashi1,5.   

Abstract

Acquired coagulation factor deficiency is a rare bleeding disorder caused by the inhibitors to coagulation factors. We report a case of an elderly hemodialysis patient who presented with the intermittent hematuria and anemia, associated with the prolonged activated partial thromboplastin time and prothrombin time. Laboratory examination revealed undetectable factor VIII activity, decreased factor V activity, and the presence of inhibitors to these coagulation factors. The patient was diagnosed to have inhibitors to coagulation factors VIII and V simultaneously. In addition, hematuria was found to be caused by the right renal hemorrhage. Renal extravasation was treated by transcatheter arterial embolization. Oral prednisolone successfully eradicated the inhibitors. The present case highlights the importance to consider acquired coagulation factor inhibitors for bleeding symptoms, because they are sometimes life-threatening.

Entities:  

Keywords:  Acquired hemophilia A; Coagulation factors; Hemodialysis; Kidney

Year:  2016        PMID: 28508982      PMCID: PMC5411649          DOI: 10.1007/s13730-016-0229-y

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  6 in total

1.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

Authors:  Peter W Collins; Sybil Hirsch; Trevor P Baglin; Gerard Dolan; John Hanley; Michael Makris; David M Keeling; Ri Liesner; Simon A Brown; Charles R M Hay
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

Review 2.  Management of acquired haemophilia A.

Authors:  P W Collins
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis.

Authors:  N Narukawa; T Abe; M Shouno; Y Kitabata; M Okamoto; H Kobata; T Akizawa
Journal:  Ther Apher       Date:  1999-11

Review 4.  The molecular basis of factor V and VIII procofactor activation.

Authors:  R M Camire; M H A Bos
Journal:  J Thromb Haemost       Date:  2009-09-18       Impact factor: 5.824

Review 5.  Acquired factor V inhibitor. A problem-based systematic review.

Authors:  Ai Leen Ang; Ponnudurai Kuperan; Chin Hin Ng; Heng Joo Ng
Journal:  Thromb Haemost       Date:  2009-05       Impact factor: 5.249

Review 6.  Acquired haemophilia: an overview for clinical practice.

Authors:  Craig M Kessler; Paul Knöbl
Journal:  Eur J Haematol       Date:  2015-12       Impact factor: 2.997

  6 in total
  1 in total

1.  Acquired factor V inhibitor with erythema and eosinophilia in a patient with end-stage renal disease.

Authors:  Eisuke Katsuren; Kentaro Kohagura; Takanori Kinjyo; Ryo Zamami; Takuto Nakamura; Nanako Oshiro; Yoshitsugu Sunagawa; Kumiko Omine; Yuki Kudo; Yuki Shinzato; Tsukasa Osaki; Masayoshi Souri; Akitada Ichinose; Masanobu Yamazato; Akio Ishida; Yusuke Ohya
Journal:  CEN Case Rep       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.